OncoImmunology

Top Research Topics at OncoImmunology?

The journal mainly deals with areas of study such as Immunology, Cancer research, Immune system, Immunotherapy and Cancer. The journal focuses on Immunology but the discussions also offer insight into other areas such as Cytotoxic T cell and Melanoma. It dives deep in exploring the relationship between the study of Cytotoxic T cell and Cell biology.

The research on Cancer research tackled can also make contributions to studies in the areas of Cancer cell, T cell, CD8 and Immune checkpoint. The research on Immune system featured in OncoImmunology combines topics in other fields like Cell, Antibody and Cytokine. Topics in Immunotherapy explored in OncoImmunology were investigated in conjunction with research in Monoclonal antibody, Blockade and Oncology.

The main emphasis of it is the research on Internal medicine, emphasizing the topic of Chemotherapy. OncoImmunology investigates Interleukin 21 research which frequently intersects with Interleukin 12.

• Immunology (47.87%)
• Cancer research (47.36%)
• Immune system (36.33%)

What are the most cited papers published in the journal?

• Consensus guidelines for the detection of immunogenic cell death (490 citations)
• Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC (333 citations)
• Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. (278 citations)

Research areas of the most cited articles at OncoImmunology:

The published papers are mainly concerned with subjects like Immunology, Immune system, Cancer research, Immunotherapy and Cancer. The most cited articles explore research in Immunology alongside concepts in Cytotoxic T cell and other areas of study in Cell biology. The published papers facilitate discussions on Immune system that incorporate concepts from other fields like Cancer cell and Antibody.

What topics the last edition of the journal is best known for?

• Cancer
• Gene
• Internal medicine

The previous edition focused in particular on these issues:

OncoImmunology is mainly concerned with subjects like Cancer research, Immunotherapy, Immune system, Tumor microenvironment and Cancer. The journal explores issues in Cancer research which can be linked to other research areas like T cell, CD8, PD-L1, Cytotoxic T cell and Antibody. OncoImmunology focuses on T cell research as part of the broader topic of Immunology.

The research on Immunotherapy featured in OncoImmunology combines topics in other fields like Biomarker (medicine) and Oncology. Oncolytic virus research are fields of study within Immune system but they also intertwine with concepts in Context (language use). The work on Tumor microenvironment tackled in the journal brings together disciplines like Microsatellite instability, Immunity, Melanoma, Tumor progression and Colorectal cancer.

The most cited articles from the last journal are:

• Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo. (6 citations)
• Ferroptosis becomes immunogenic: implications for anticancer treatments (6 citations)
• M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in OncoImmunology (based on the number of publications) are:

• Guido Kroemer (148 papers) published 9 papers at the last edition, 13 less than at the previous edition,
• Laurence Zitvogel (119 papers) published 1 paper at the last edition, 9 less than at the previous edition,
• Lorenzo Galluzzi (97 papers) published 4 papers at the last edition, 4 less than at the previous edition,
• Jérôme Galon (48 papers) published 5 papers at the last edition, 2 less than at the previous edition,
• Erika Vacchelli (46 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in OncoImmunology (based on the number of publications) are:

• French Institute of Health and Medical Research (171 papers) published 12 papers at the last edition, 12 less than at the previous edition,
• Institut Gustave Roussy (130 papers) published 8 papers at the last edition, 11 less than at the previous edition,
• Paris Descartes University (124 papers) absent at the last edition,
• German Cancer Research Center (74 papers) published 4 papers at the last edition the same number as at the previous edition,
• University of Texas MD Anderson Cancer Center (72 papers) published 7 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.86% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.59% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.75% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.18% of all publications and 50.49% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.